3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Cytomegalovirus Retinitis: new trials by email Literature Review of Cytomegalovirus Retinitis trials Research Report on Cytomegalovirus Retinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Cidofovir pharmacokinetics - Cytomegalovirus Retinitis, Acute Renal Failure | Phase 4 | Completed | Medical University of Vienna | 1 | 2002-03-01 | 2013-06-05 |
| A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections | Phase 4 | Completed | Astra USA | 112 | 2005-06-24 | |
| Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Cidofovir, Probenecid, Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2011-02-23 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Acute Kidney Injury (1) · Cytomegalovirus Infections (1) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1) · Retinitis (1)
DNA Virus Infections (3) · Eye Diseases (3) · Eye Infections (3) · Eye Infections, Viral (3) · Herpesviridae Infections (3) · Infections (3) · Retinal Diseases (3) · Urogenital Diseases (3) · Virus Diseases (3) · Blood-Borne Infections (2) · Communicable Diseases (2) · Cytomegalovirus Infections (2) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2)
Cidofovir (1) · Foscarnet (1) · Ganciclovir (1) · Probenecid (1)
Astra USA (1) · Medical University of Vienna (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · Austria (1)
Florian Thalhammer, Prof. MD (1) · Wool GM (1)